Cargando…

Amelioration of Cerebral Ischemic Injury by a Synthetic Seco-nucleoside LMT497

Recently, we reported that the A3 adenosine receptor (A(3)AR) agonist LJ529 (2-chloro-N(6)-(3-iodobnzyl)-5'-N-methylcarbamoyl-4'-thioadenosine) reduces cerebral ischemic injury via inhibition of recruitment of peripheral inflammatory cells into ischemic brain lesion. A3AR agonists, however...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryu, Sangwoo, Kwon, Joonha, Park, Hyeon, Choi, In-Young, Hwang, Sunyoung, Gajulapati, Veeraswamy, Lee, Joo Young, Choi, Yongseok, Varani, Katia, Borea, Pier Andrea, Ju, Chung, Kim, Won-Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Brain and Neural Science 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363332/ https://www.ncbi.nlm.nih.gov/pubmed/25792868 http://dx.doi.org/10.5607/en.2015.24.1.31

Ejemplares similares

In vitro and in vivo pharmacokinetic characterization of LMT-28 as a novel small molecular interleukin-6 inhibitor
por: Ahn, Sung-Hoon, et al.
Publicado: (2020)

Self-Trained LMT for Semisupervised Learning
por: Fazakis, Nikos, et al.
Publicado: (2016)

Anxiolytic properties of A(1) adenosine receptor PAMs
por: Vincenzi, Fabrizio, et al.
Publicado: (2016)

Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity
por: Anthony Jalin, Angela M. A., et al.
Publicado: (2015)

Getting to Phase 3: an Interview with Virginia S. Cowen, PhD, LMT
por: Kennedy, Ann Blair
Publicado: (2017)

Seco debíl, seco fuerte e impresión: Atlas de Histología./
Publicado: (1980)

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

Anti-Differentiation Effect of B, D-Seco limonoids of Swietenia mahogani
por: Yang, Heejung, et al.
Publicado: (2017)

Ojo seco - dry eye /
Publicado: (1997)

Adenosine and Inflammation: Here, There and Everywhere
por: Pasquini, Silvia, et al.
Publicado: (2021)

Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes
por: Choi, Woo Jin, et al.
Publicado: (2020)

Seco-sativene and Seco-longifolene Sesquiterpenoids from Cultures of Endophytic Fungus Bipolaris eleusines
por: Yang, Man-Si, et al.
Publicado: (2017)

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
por: Pasquini, Silvia, et al.
Publicado: (2022)

Síndrome de ojo seco
por: Fuente Poo, Gerardo Sainz de la
Publicado: (1995)

Síndrome de ojo seco
por: Sainz De la Fuente Poo, Gerardo
Publicado: (1995)

Striving to Make Massage Therapy Accessible to Older Adults: an Interview with Niki Munk, PhD, LMT
por: Kennedy, Ann Blair
Publicado: (2018)

Bioactive Natural Spirolactone-Type 6,7-seco-ent-Kaurane Diterpenoids and Synthetic Derivatives
por: Li, Haonan, et al.
Publicado: (2018)

El cantaro seco : pieza de un acto
por: Cárdenas, Nancy
Publicado: (1960)

LMT(db): A comprehensive transcriptome database for climate-resilient, nutritionally rich little millet (Panicum sumatrense)
por: Shekhar, Shweta, et al.
Publicado: (2023)

Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors
por: Gessi, Stefania, et al.
Publicado: (2006)

A(2A )and A(3 )adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release
por: Varani, Katia, et al.
Publicado: (2011)

A(2A) adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus
por: Bortoluzzi, Alessandra, et al.
Publicado: (2016)

The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A(1)AR Positive Allosteric Modulation
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-like SH-SY5Y Cells from Oxygen-Glucose Deprivation
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

A(1) Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
por: Pasquini, Silvia, et al.
Publicado: (2022)

Construcción en climas cálidos secos
por: Saini, Balwant Singh
Publicado: (1987)

A(2A) Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats
por: Vincenzi, Fabrizio, et al.
Publicado: (2013)

Noble 3,4-Seco-triterpenoid Glycosides from the Fruits of Acanthopanax sessiliflorus and Their Anti-Neuroinflammatory Effects
por: Choi, Bo-Ram, et al.
Publicado: (2021)

Bolstering the Three Pillars of the Essential Architecture of the Massage Therapy Profession: an Interview with Glenn M. Hymel, EdD, LMT
por: Kennedy, Ann Blair
Publicado: (2018)

Frutos tropicales secos/deshidratados : Estudios de algunos mercados importantes
Publicado: (1994)

Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes
por: Pasquini, Silvia, et al.
Publicado: (2020)

A(2A) Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?
por: Merighi, Stefania, et al.
Publicado: (2022)

Diccionario de dudas de Manuel Seco
por: Seco, Manuel, 1928-
Publicado: (1999)

Synthesis of the B-seco limonoid core scaffold
por: Bruss, Hanna, et al.
Publicado: (2014)

The seco-iridoid pathway from Catharanthus roseus
por: Miettinen, Karel, et al.
Publicado: (2014)

Structural Necessity of Indole C5-O-Substitution of seco-Duocarmycin Analogs for Their Cytotoxic Activity
por: Choi, Taeyoung, et al.
Publicado: (2010)

An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
por: Merighi, Stefania, et al.
Publicado: (2021)

A(2A) Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
por: Gessi, Stefania, et al.
Publicado: (2021)

Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A(3) adenosine receptor
por: Merighi, Stefania, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_o7h8941kt3osqj8ua3mv3ac8su